Selected article for: "beta alpha and wild type alpha"
Author: Liu, Yang; Liu, Jianying; Zou, Jing; Ren, Ping; Weaver, Scott C.; Xie, Xuping; Shi, Pei-Yong
Title: Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
  • Cord-id: mrt0j152
  • Document date: 2021_9_2
    • ID: mrt0j152
    Snippet: The rapid evolution of SARS-CoV-2 mandates a better understanding of cross-protection between variants after vaccination or infection, but studies directly evaluating such cross-protection are lacking. Here we report that immunization with different variant spikes elicits distinct neutralizing kinetics and magnitudes against other SARS-CoV-2 variants. After immunizing hamsters with wild-type or mutant SARS-CoV-2 bearing variant spikes from Alpha, Beta, Gamma, or Epsilon, the animals developed fa
    Document: The rapid evolution of SARS-CoV-2 mandates a better understanding of cross-protection between variants after vaccination or infection, but studies directly evaluating such cross-protection are lacking. Here we report that immunization with different variant spikes elicits distinct neutralizing kinetics and magnitudes against other SARS-CoV-2 variants. After immunizing hamsters with wild-type or mutant SARS-CoV-2 bearing variant spikes from Alpha, Beta, Gamma, or Epsilon, the animals developed faster and greater neutralization activities against homologous SARS-CoV-2 variants than heterologous variants, including Delta. The rank of neutralizing titers against different heterologous variants varied, depending on the immunized variant spikes. The differences in neutralizing titers between homologous and heterologous variants were as large as 62-, 15-, and 9.7-fold at days 14, 28, and 45 post-immunization, respectively. Nevertheless, all immunized hamsters were protected from challenges with all SARS-CoV-2 variants, including those exhibiting the lowest neutralizing antibody titers. The results provide insights into the COVID-19 vaccine booster strategies.

    Search related documents:
    Co phrase search for related documents
    • absolute quantification and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • active remain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • active remain and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • active remain and add protection: 1
    • acute respiratory syndrome and add protection: 1
    • acute respiratory syndrome and adenovirus expression: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and log10 value: 1, 2
    • acute respiratory syndrome and long term strategy: 1, 2, 3, 4
    • acute respiratory syndrome and low neutralizing titer: 1
    • acute respiratory syndrome coronavirus and add protection: 1
    • acute respiratory syndrome coronavirus and adenovirus expression: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome coronavirus and log10 value: 1
    • acute respiratory syndrome coronavirus and long term strategy: 1, 2
    • acute respiratory syndrome coronavirus and low neutralizing titer: 1